FRASER & COMPANY | TRIMURTHI DRUGS | FRASER & COMPANY/ TRIMURTHI DRUGS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -17.2 | -55.3 | - | View Chart |
P/BV | x | 0.5 | 1.9 | 27.0% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
FRASER & COMPANY TRIMURTHI DRUGS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
FRASER & COMPANY Mar-23 |
TRIMURTHI DRUGS Mar-23 |
FRASER & COMPANY/ TRIMURTHI DRUGS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 11 | 11 | 97.1% | |
Low | Rs | 6 | 7 | 77.7% | |
Sales per share (Unadj.) | Rs | 12.9 | 1.7 | 746.1% | |
Earnings per share (Unadj.) | Rs | 0.4 | -0.1 | -568.6% | |
Cash flow per share (Unadj.) | Rs | 0.6 | 0 | -11,521.6% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 9.8 | 8.9 | 110.9% | |
Shares outstanding (eoy) | m | 8.12 | 8.10 | 100.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 5.2 | 12.0% | |
Avg P/E ratio | x | 19.3 | -122.7 | -15.7% | |
P/CF ratio (eoy) | x | 14.3 | -1,963.5 | -0.7% | |
Price / Book Value ratio | x | 0.8 | 1.0 | 80.8% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 66 | 74 | 89.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2 | 2 | 118.5% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 105 | 14 | 747.9% | |
Other income | Rs m | 0 | 5 | 0.4% | |
Total revenues | Rs m | 105 | 19 | 547.4% | |
Gross profit | Rs m | 7 | -5 | -127.2% | |
Depreciation | Rs m | 1 | 1 | 214.3% | |
Interest | Rs m | 1 | 0 | - | |
Profit before tax | Rs m | 5 | -1 | -801.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1 | 0 | 12,200.0% | |
Profit after tax | Rs m | 3 | -1 | -570.0% | |
Gross profit margin | % | 6.3 | -36.8 | -17.0% | |
Effective tax rate | % | 26.3 | -2.5 | -1,052.8% | |
Net profit margin | % | 3.3 | -4.3 | -76.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 114 | 42 | 268.2% | |
Current liabilities | Rs m | 41 | 1 | 6,572.6% | |
Net working cap to sales | % | 69.5 | 297.6 | 23.4% | |
Current ratio | x | 2.8 | 68.4 | 4.1% | |
Inventory Days | Days | 64 | 721 | 8.9% | |
Debtors Days | Days | 366,539,249 | 49,478 | 740,806.4% | |
Net fixed assets | Rs m | 21 | 29 | 72.4% | |
Share capital | Rs m | 81 | 81 | 100.2% | |
"Free" reserves | Rs m | -1 | -9 | 13.6% | |
Net worth | Rs m | 80 | 72 | 111.1% | |
Long term debt | Rs m | 3 | 0 | - | |
Total assets | Rs m | 135 | 72 | 187.9% | |
Interest coverage | x | 7.0 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.2 | 398.0% | |
Return on assets | % | 3.1 | -0.8 | -373.9% | |
Return on equity | % | 4.3 | -0.8 | -513.7% | |
Return on capital | % | 6.5 | -0.8 | -806.7% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2 | 1 | 237.9% | |
From Investments | Rs m | -7 | 1 | -941.3% | |
From Financial Activity | Rs m | NA | NA | - | |
Net Cashflow | Rs m | -5 | 2 | -275.9% |
Indian Promoters | % | 3.1 | 66.9 | 4.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 96.9 | 33.1 | 292.9% | |
Shareholders | 6,193 | 2,635 | 235.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare FRASER & COMPANY With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA NOVARTIS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | FRASER & COMPANY | TRIMURTHI DRUGS |
---|---|---|
1-Day | 1.78% | 0.00% |
1-Month | 5.10% | 0.00% |
1-Year | -3.20% | 77.22% |
3-Year CAGR | -3.04% | 30.81% |
5-Year CAGR | -10.62% | 19.68% |
* Compound Annual Growth Rate
Here are more details on the FRASER & COMPANY share price and the TRIMURTHI DRUGS share price.
Moving on to shareholding structures...
The promoters of FRASER & COMPANY hold a 3.1% stake in the company. In case of TRIMURTHI DRUGS the stake stands at 66.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of FRASER & COMPANY and the shareholding pattern of TRIMURTHI DRUGS.
Finally, a word on dividends...
In the most recent financial year, FRASER & COMPANY paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
TRIMURTHI DRUGS paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of FRASER & COMPANY, and the dividend history of TRIMURTHI DRUGS.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.